Chris Brinsmead

Chris has worked in the pharmaceutical industry for over 30 years, holding executive leadership roles with ICI, and Zeneca, before becoming Chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland (2001 – 2010), and President of the Association of the British Pharmaceutical Industry (ABPI) from 2008-2010. Since leaving executive roles, Chris has taken on a number of advisory and Non-Executive Director positions in private and public companies.

Advisory positions include independent advisor to the Prime Minister and other senior government ministers for life sciences (2010-2017) and advisor to Sodexo Healthcare (2010-2017). Chris is currently the Chairman of two companies – Scapa Plc and Proveca Ltd and is a member of the council at Imperial College.

Other non-executive positions include UDG Healthcare plc (2017- 2019) and chairman of Consort Medical plc (2019-2020), an FTSE 350 company that was sold during Chris’s leadership to Recipharm for £505m in February 2020. Chris was Chairman of Collagen Solutions plc from 2019 to 2020, leading its sale to Rosen’s Diversified Inc. Chris was appointed a CBE in January 2015.